# The Medicines for Human Use (Clinical Trials) Regulations 2004, Paragraph 4


The holder of the authorisation shall—
(a) inform the licensing authority before making any structural alterations to, or discontinuance of the use of, premises to which his authorisation relates; and
(b) inform the licensing authority if he changes the person named as the qualified person for the purposes of regulation 43 and paragraph 9.

---
Source: https://www.legislation.gov.uk/uksi/2004/1031/schedule/7/part/3/paragraph/4 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-regulations-2004/schedule-7/part-3/paragraph-4
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.